Skip to Content

Tag: Testing


Also Noted

PSN Labs responds to Philips lawsuit 

October 7, 2024HME News Staff

PITTSBURGH – PSN Labs has disputed claims made by Philips that the lab caused “significant damage” to the company by conducting “numerous egregious errors in its testing and analysis” related to recalled sleep and respiratory devices. In a response filed Sept. 27 in the U.S. District Court for the Western District of Pennsylvania, PSN says the company “has continued to mischaracterize testing results in an effort to conceal the ultimate foam degradation issue.”...

CPAP Recall, Lawsuit, Philips, PSN Labs, Testing


Read Full Articlered right arrow icon

Vendors

Philips blames lab for breadth of recall 

August 5, 2024HME News Staff

PITTSBURGH – Philips says PSN Labs conducted “numerous egregious errors in its testing and analysis” related to the company’s recalled sleep and respiratory devices, causing it “significant damage.”  In a lawsuit filed July 29 in U.S. District Court for the Western District of Pennsylvania, Philips says PSN’s work was a big reason it initiated a worldwide recall of more than 15 million sleep and respiratory devices in June 2021 and that the company...

CPAP Recall, Philips, PSN Labs, Testing


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Philips on completed testing: ‘Assessments are positive and reassuring’ 

May 16, 2023HME News Staff

AMSTERDAM – Royal Philips has released a completed set of test results for the first-generation DreamStation, System One and DreamStation Go sleep therapy devices that indicate potential patient exposure to foam particulate matter (PM) and volatile organic compounds (VOCs) from the PE-PUR foam in these devices is unlikely to result in appreciable harm to health in patients.  The results, which have been shared with the U.S. Food and Drug Administration and other authorities, are the...

CPAP Recall, Philips, Testing


Read Full Articlered right arrow icon

Vendors

Philips provides ‘encouraging’ testing update

June 28, 2022HME News Staff

AMSTERDAM – A comprehensive testing and research program on the PE-PUR foam in certain CPAP, BiPAP and mechanical ventilator devices has shown very low prevalence of visible degradation, Philips announced in an update on June 28.  In first-generation DreamStation devices, which represent 68% of registered affected devices globally, testing found:   164 of 36,341 (0.5%) devices with self-reported no ozone use showed significant visible foam degradation.  777...

CPAP, PE-PUR, Philips Recall, Sound Abatement Foam, Testing


Read Full Articlered right arrow icon

Also Noted

NCPA urges other states to follow New York's lead

April 28, 2020HME News Staff

ALEXANDRIA, Va. - The National Community Pharmacists Association, which represents more than 21,000 independent pharmacies across the country, lauds New York Gov. Andrew Cuomo for authorizing independent pharmacies to serve as COVID-19 test centers. “We are deeply grateful to Gov. Cuomo for enlisting independent pharmacies in the fight against the pandemic,” said CEO B. Douglas Hoey. “Local pharmacies in New York and every state have been fighting for the authority to do testing...

Community Pharmacy, National Community Pharmacists Association (NCPA), Testing


Read Full Articlered right arrow icon

Also Noted

Short takes: sleep apnea

May 16, 2017HME News Staff

The U.S. Supreme Court's refusal to hear a case from a truck driver who claimed his employer violated his rights by requiring him to get tested for sleep apnea opens the door for trucking companies to more widely require the tests, according to Trucks.com. The court's decision in April follows Robert Parker's appeal of a lower court decision that Crete Carrier didn't violate his rights under the American with Disabilities Act when it required him to be tested because he had a body mass index of 35...

Military, Sleep Apnea, Testing, trucking


Read Full Articlered right arrow icon

Specialty Providers

Breathalyzer targets 'stunningly low' compliance for glucose checks

January 3, 2017Theresa Flaherty, Managing Editor

For decades, researchers have sought to find noninvasive ways for people with diabetes to test their blood glucose levels without the dreaded finger stick. Western New England University professors Dr. Ronny Priefer and Dr. Michael Rust have developed a handheld breathalyzer that detects acetone levels in a user's breath that correlate with blood glucose levels. Dr. Priefer spoke with HME News recently about the quest for pain-free glucose checks. HME News: How does the breathalyzer work? Dr....

Blood Glucose Monitor, Diabetes, Dr. Ronny Priefer, Testing


Read Full Articlered right arrow icon

Also Noted

NJ Transit takes 11 off rails…

December 16, 2016HME News Staff

NEWARK, N.J. - Eleven New Jersey Transit train engineers or conductors have been temporarily removed from duty under a new program to assess fatigue-related conditions like obstructive sleep apnea, according to news reports. Under the program, launched in October, engineers and conductors who show indications of potential fatigue symptoms will be removed until they can document that they've controlled or corrected their conditions, according to reports. Previously, NJ Transit allowed engineers with...

sleep regs, Testing, train


Read Full Articlered right arrow icon

Also Noted

…Truck drivers challenge fed on sleep

December 16, 2016HME News Staff

GRAIN VALLEY, Miss. - The Owner-Operator Independent Drivers Association filed a petition on Dec. 14 challenging language related to sleep apnea in the Federal Motor Carrier Safety Administration's final rule on medical examiner certification, according to the Journal of Commerce. The appendix of the rule states: “If the medical examiner detects a respiratory dysfunction, that in any way is likely to interfere with the driver's ability to safely control and drive a commercial motor vehicle,...

sleep regs, Testing, truck drivers


Read Full Articlered right arrow icon

Also Noted

Survey finds low awareness of OSA screening, testing

October 3, 2013HME News Staff

GLEN BURNIE, Md. - There's a clear lack of awareness among Americans about the latest screening and testing technologies for obstructive sleep apnea (OSA), according to a survey commissioned by NovaSom and the American Sleep Apnea Association. The survey, which polled 500 men and women between the ages of 30 and 65, found that 88% were unaware of either the Epworth or Stop-Bang questionnaires, and 82% were unaware of home sleep tests. Additionally, it found 40% who suspected themselves or a spouse/partner...

Awareness, NovaSom, Sleep Apnea, Survey, Testing


Read Full Articlered right arrow icon